Cite
HARVARD Citation
Smolen, J. et al. (2014). Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study. Annals of the rheumatic diseases. 73 (10), pp. 1811-1818. [Online].